Work

Gemcitabine and docetaxel in patients with measurable unresectable or metastatic hepatocellular carcinoma (HCC), a North Central Cancer Treatment Group (NCCTG) phase II trial

Year: 2004

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2004.22.14_suppl.4270

Authors: G. P. Kim, S. R. Alberts, L. K. Tschetter, T. R. Fitch, S. R. Dakhil, B. W. Morlan, D. J. Sargent

Institution: North Central Cancer Treatment Group

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2344175195

Cites:

Cited by: 2

Related to: 10